Automated Identification of Fall-related Injuries in Unstructured Clinical Notes.
Ge W, Coelho LMG, Donahue MA, Rice HJ, Blacker D, Hsu J, Newhouse JP, Hernandez-Diaz S, Haneuse S, Westover MB, Moura LMVR.
Am J Epidemiol. 2024 Jul 26. PMID: 39060160
Other Positions
Director, Pharmacoepidemiology Program
Epidemiology
Harvard T.H. Chan School of Public Health
Links
Overview
Sonia Hernandez-Diaz, MD, DrPH is a Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. Her area of interest is drug safety evaluation from non-randomized data, with a special emphasis on the design, conduct, and analysis of studies in pregnant women and their infants. Examples of her work include inquiries of the comparative safety of psychotropics for pregnant women and their offspring using real world evidence from both pregnancy registries and large healthcare databases. She is Past-President of the International Society for Pharmacoepidemiology and the Society for Perinatal and Pediatric Epidemiology Research; and serves as a Special Government Employee for the FDA Drug Safety and Risk Management Advisory Committee (current Chair), as a member of the NICHD Pregnancy & Neonatology (PN) Study Section, and as member of the Teratogenic Information Services (TERIS) Advisory Board. Through her service to public health institutions she has contributed to the translation of research into policy and actionable recommendations for stakeholders.
Bibliography
Perspectives on drug development for the treatment of chronic myeloid leukemia in pregnant patients and patients who are breastfeeding.
Cortes JE, Abruzzese E, Cardonick EH, Hernandez-Diaz S, Gutierrez J, Sardegna MS, Torres-Chavez E, Dinatale M, Lerro CC, Gehrke BJ, Shord SS, de Claro RA, Theoret MR, DeMaria PJ, Norsworthy KJ.
Clin Cancer Res. 2024 Jul 05. PMID: 38967550
First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort.
Fung K, Hernandez-Diaz S, Zash R, Chadwick EG, Van Dyke RB, Broadwell C, Jao J, Powis K, Yee LM, Williams PL.
AIDS. 2024 Sep 01. 38(11):1686-1695. PMID: 38864586
Use of Real-World Data and Machine Learning to Screen for Maternal and Paternal Characteristics Associated with Cardiac Malformations.
Brown J, Huybrechts K, Straub L, Heider D, Bateman B, Hernandez-Diaz S.
Res Sq. 2024 Jun 11. PMID: 38947037
The association of short-term increases in ambient PM2.5 and temperature exposures with stillbirth: racial/ethnic disparities among Medicaid recipients.
Shupler M, Huybrechts K, Leung M, Wei Y, Schwartz J, Hernandez-Diaz S, Papatheodorou S.
Am J Epidemiol. 2024 May 20. PMID: 38770979
Association between density of food retailers and fitness centers and gestational diabetes mellitus in Eastern Massachusetts, USA: population-based study.
Shupler M, Klompmaker JO, Leung M, Petimar J, Drouin-Chartier JP, Modest AM, Hacker M, Farid H, James P, Hernandez-Diaz S, Papatheodorou S.
Lancet Reg Health Am. 2024 Jul. 35:100775. PMID: 38803547
Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.
Suarez EA, Bateman BT, Hernandez-Diaz S, Straub L, McDougle CJ, Wisner KL, Gray KJ, Pennell PB, Lester B, Zhu Y, Mogun H, Huybrechts KF.
JAMA Psychiatry. 2024 May 01. 81(5):477-488. PMID: 38265792
Prediction of pregnancy-related complications in women undergoing assisted reproduction, using machine learning methods.
Wang C, Johansson ALV, Nyberg C, Pareek A, Almqvist C, Hernandez-Diaz S, Oberg AS.
Fertil Steril. 2024 Jul. 122(1):95-105. PMID: 38373676
Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy.
Cohen JM, Alvestad S, Suarez EA, Schaffer A, Selmer RM, Havard A, Bateman BT, Cesta CE, Zoega H, Odsbu I, Huybrechts KF, Kjerpeseth LJ, Straub L, Leinonen MK, Bjørk MH, Nørgaard M, Gissler M, Ulrichsen SP, Hernandez-Diaz S, Tomson T, Furu K.
Neurology. 2024 Jan 23. 102(2):e207996. PMID: 38165339
Overweight or obesity in children born after assisted reproductive technologies in Denmark: A population-based cohort study.
Laugesen K, Veres K, Hernandez-Diaz S, Chiu YH, Oberg AS, Hsu J, Rinaudo P, Spaan M, van Leeuwen F, Sørensen HT.
PLoS Med. 2023 Dec. 20(12):e1004324. PMID: 38113196
News
Prenatal exposure to antiseizure medication topiramate may not increase children’s risk of autism spectrum disorder
Prenatal exposure to topiramate, an antiseizure medication prescribed to treat epilepsy as well as migraines and bipolar disorder, does not appear to increase kids' risk of autism spectrum disorder, according to a new study led by Harvard T.H.…
The importance of studying treatments in pregnant people
At the 16th Kolokotrones Symposium, experts discussed the importance of including pregnant people when testing vaccines and drugs, the challenges of collecting data for that population, and research methods that could help fill the data gap.
Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk to infants than insulin
Infants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications during pregnancy are at no higher risk of major congenital malformations than infants born to those who take insulin, according to a new…
‘Crossroads’ conversations: Faculty, alums share key career moments with students
Harvard Chan faculty and alumni shared stories about major transitional moments in their careers and lives at an October 16 dinner with students.
Evaluating the safety of TDF, an HIV drug, for pregnant women facing COVID-19
Among pregnant women who use the HIV drug tenofovir disoproxil fumarate, there was no greater risk of malformations in their newborns than from other antiretroviral therapies, according to new research from Harvard Chan School.